TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria October 22, 2010
TCL Archive In Brief: ACS Board Names McGinnis Prsident; Fuller Re-Elected chairman; Lenhard Is Vice President November 25, 1994
TCL Archive In Brief: Capp Heads Roentgen Ray Society; Annual Lecture, Chair Honors Charles Spurr June 22, 1990